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HeadacheAbstract Background: Migraine is a chronic neurological disease characterized by recurrent mod-
erate to severe headaches commonly in association with neuro-inflammation. Interleukin-4 (IL-4),
an anti-inflammatory cytokine, plays an important role in modulating pain threshold and has an
essential role in stimulation of pain receptors in the trigeminal nerve fibers.
Aim of the study: The current study aimed to investigate the possible associations between IL-4
single nucleotide polymorphisms (SNPs) and susceptibility to migraine in Iranian patients.
Patients and methods: In a prospective case–control study, we studied blood samples of 190
patients with migraine (migraineurs) and 200 healthy controls (HCs) for analysis of gene variants.
Genotyping for the IL-4 SNPs: C-589T (rs2243250), T+2979G (rs2227284), and C-33T (rs2070874)
were performed using PCR-RFLP. Statistical analysis was performed using the SPSS version 21.0
(SPSS, Chicago) and SNPStats version 1.14.0.
Results and conclusion: Among IL-4 SNPs, rs2243250 (TC genotype, OR= 0.25, 95%
CI = 0.13–0.50, P= 0.001) and rs2227284 (TG and TT genotypes, OR= 0.44, 95% CI = 0.23–
0.92, P= 0.029 and OR= 0.38, 95% CI = 0.18–0.79, P= 0.009 respectively) were significantly; CCR2,
s, single
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susceptibility in Iranian population: A case–associated with migraine. No significant associations between IL-4 SNP rs2070874 (TC, TT and CC
genotypes) and migraine were found. The most frequent genotypes in the migraineurs were CC in
both SNPs rs2243250 (79%), and rs2070874 (71.5%), as well as GG for SNP rs2227284 (64%).
There was no statistically significant relationship between these SNPs and different subclasses (com-
mon, classic and complicated) of migraine. Our findings revealed that in IL-4 rs2243250 and
rs2227284 genotypes and allele frequencies have a role in susceptibility to migraine in our popula-
tion. Therefore, it is suggested that in addition to other factors, IL-4 genetic variations also play a
pivotal role in the progress of migraine.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Migraine is a rigorous and painful headache accompanying
with sensory warning and is a public health problem of great
impact on both the patient and society [1]. The two major sub-
classes of migraine are common migraine (without aura) and
classic migraine (with aura or neurological symptoms) [2].
Since about half of migraineurs do not pursue medical atten-
tion and there is no economic, social or ethnic limitation, it
is difficult to precisely determine disease prevalence in the com-
munity [3]. It seems that about 15 to 16% of women and 5 to
9% of men are affected with migraine and its prevalence is the
highest among the ages of 30–49 worldwide [4]. Migraine etiol-
ogy is multifactorial, involving both various genetic and envi-
ronmental factors, but scientists consider three important
mechanisms for its pathophysiology including: inflammatory,
neurological and cardiovascular impairments [5,6]. Cell and
molecular association studies may point to the novel molecules
that mediate migraine disorder and enable its management.
According to the theory of neuroinflammation, in the
migraine, ion channels (Na2+, Ca2+, K2+) and inflammatory
mediator (TNF-a and IL-1b) activation in the meninges sen-
sory nerves, stimulates pain receptors in these area [7,8]. In
addition to changes in the inflammatory cytokines, variations
in the anti-inflammatory mediators in migraine patients have
been reported but there are conflicting results on the mecha-
nisms involved [9–14]. The interaction between immune cells
is regulated by several mediators, including interleukins and
cytokines, which play an essential role in pathobiological pro-
cesses such as, inflammation, immunity and pain [15]. Widely,
interleukins and their receptors are present in both peripheral
neurovascular inflammation at meningeal/ganglia level, and
essential sensitization processes in central nervous system
(CNS) and likely to be involved in pain threshold modulation
[16–21]. On the other hand, peripheral blood interleukins oper-
ate mainly at a level of areas innervated by trigeminal ganglion
neurons related to neurovascular system [22]. The human IL-4
gene is located on chromosome 5q31 and consists of 25 kb. So
far, numerous allelic variant polymorphisms (http://www.ncbi.
nlm.nih.gov/SNP/) have been found in IL-4 gene, that the
important ones are including 590C/T (rs2243250), 33C/T
(rs2070874), +3437C/G (rs2227282), and 2979G/T
(rs2227284) [23]. To understand the probable role of IL-4, as
anti-inflammatory cytokine, in migraine headaches in the lead-
ing research we analyzed its imperative polymorphisms in
migraineurs with three different subclass of disease and com-
pared them to healthy controls.N et al., Association between interleuk
control study, Egypt J Med Hum Gene2. Subjects and methods
2.1. Patients and samples
The study was approved by the ethics in medical research com-
mittee at Zahedan University of Medical Sciences, and was
conducted with clinical samples from migraine patients
(N= 190, age: 13 to 66 years, age mean ± SD: 31.72
± 10.17) who were treated at the Department of Neurology,
Ali-ebn Abitaleb Hospital, Zahedan, Iran, from August 2013
to February 2014. Healthy controls (HCs) without any inflam-
matory, neurological diseases, migraine headache and specific
systemic disease (N= 200, age: 15 to 75 years, age mean
± SD: 35.1 ± 12.2) from volunteer blood donors were
selected during the same time. A diagnosis of migraine was
made according to standardized criteria of international head-
ache classification [24]. Patients were excluded if they had a
history of inflammatory diseases or received anti-
inflammatory medicines. Patients adjusted in three definite
groups including common (without aura, N= 96, 64 female
and 32 male, age mean ± SD: 31.0417 ± 10.457) classic (with
aura, N= 78, 56 female and 22 male, age mean ± SD: 32.33
± 10.57) and complicated (N= 16, 4 male and 12 female, age
mean ± SD: 32.87 ± 6.46) subtypes of migraine. All patients
were informed of the study and participated voluntarily and
written consents were taken. The work is carried out in accor-
dance with the code of Ethics of the World Medical Associa-
tion (Declaration of Helsinki) for experiments in humans.
2.2. Blood collection and DNA extraction
Whole blood (10 mL) samples were taken from all subjects and
collected in separator tubes (contain EDTA, 0.5 M) and cen-
trifuged for 15 min at 150 g (gravity) at 20 C and then serum
was stored at 20 C in sterile plastic tubes for DNA extrac-
tion. Genomic DNA was extracted from the serum of 190 sub-
jects with migraine headaches and 200 HCs using the DNA
extraction kit (DIAtom DNA Prep., GORDIZ, Moscow,
Russia) according to the manufacturer’s instruction. DNA
quality extracts were analyzed by electrophoresis. By Nano-
Drop DNA concentrations about 60 ng/ll was obtained and
ratio of 260/280 nm around 1.7 to 1.9 was accepted [25].
2.3. PCR analysis
Four IL-4 SNPs C-589T (rs2243250), T+2979G (rs2227284),
and C-33T (rs2070874) were analyzed through restrictionin-4 (IL-4), gene polymorphisms (C-589T, T+2979G, and C-33T) and migraine
t (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.05.001
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(RFLP–PCR) method [26]. PCR amplifications were per-
formed in a final volume of 20 ll containing, 10 ll master
mix (TAKARA, Tokyo, Japan), 0.7 ll (10 pmol) of each pri-
mer, 2 lL template DNA, and 6.8 ll DNase-free water was
used. For rs2070874 and rs2227284, the amplification was per-
formed with an initial denaturation step at 94 C for 5 min; fol-
lowed by 35 cycles at 94 C for 30 s, 58 C for 35 s, and 72 C
for 30 s with a final extension at 72 C for 5 min. For SNP
rs2243250, the cycling conditions were as follow: an initial
denaturation step at 94 C for 5 min, followed by 35 cycles
at 94 C for 30 s, 50 C for 30 s, and 72 C for 30 s with a final
extension at 72 C for 5 min. The PCR product was checked
for size and purity by 1.5% agarose gel electrophoresis. The
sizes of the fragments were 195bp, 220bp and 223bp for the
C-589T, T+2979G and C-33T regions, respectively (Table 1).
2.4. RFLP analysis
Final volume of 20 lL including 2 lL of 10  Buffer, 0.5 lL of
enzyme, 7 lL of PCR product, 10.5 lL of double distilled
water was used for all amplification products overnight at
37 C, and 10 lL sample loaded for electrophoresis. AvaII
(Thermo Scientific) endonuclease digested pattern for
rs2243250 amplification product were 177bp and 18bp for
the CC, 195bp, 177bp and 18bp for the TC and 195bp for
the TT genotypes (Table 1). AluI (Thermo Scientific) endonu-
clease digested pattern for rs2227284 amplification product
were 122bp and 98bp for the GG, 122bp, 98bp, 53bp, and
45bp for the TC and 122bp, 53bp, and 45bp for the TT geno-
types (Table 1). BsmAI (Thermo Scientific) endonuclease
digested pattern for rs2070874 amplification product were
178bp and 45bp for the CC, 178bp, 140bp, 45bp, and 38bp
for the TC and 140bp, 45bp, and 38bp for the TT genotypes
(Table 1).
2.5. Statistical analysis
SPSS version 21.0 (SPSS, Chicago) and SNPStats version
1.14.0 were used for all the statistical analyses. The association
between genotypes and IL-4 was estimated using the odds ratio
(OR) and 95% confidence intervals (95% CI) from logistic
regression analyses. The Hardy–Weinberg equilibrium
(HWE) was tested with the X2 test for any of the SNPs underTable 1 Primer sequences and restriction enzymes used for detectio
SNPs (rs number) Sequence (50 ? 30)
F: Forward
R: Reverse
C-33T (rs2070874) F: CAA GTT ACT GAC AAT CTG GTG T
R: CGG CAC ATG CTA GCA GGA A
C-589T (rs2243250) F: TAA ACT TGG GAG AAC ATG GT
R: TGG GGA AAG ATA GAG TAA TA
T+ 2979G (rs2227284) F: CTA CTC TTG GCA GTT GCT GGA A
R: GGA ACT CTC TGT AGA ATT ATG A
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3. Results
3.1. Association of IL-4 SNP (rs2070874 C/T) and migraine
The C/C, T/C and T/T genotypes of 33 C/T were found in
74%, 19% and 7% in HCs, in comparison with 79%, 15%
and 6% in migraineurs, respectively. The allele frequency of
IL-4 rs2070874 (C/T) were 83.5% (C), 16.5% (T) in HCs
and 86% (C), 14% (T) in migraineurs, respectively. Distribu-
tions of IL-4 polymorphisms in rs2070874 (C/T) were not sig-
nificantly different between patients and controls for TC
(OR= 0.727, P= 0.412), and TT (OR= 0.847, P= 0.773)
genotypes and also C (OR= 1.246, P= 0.438) and T
(OR= 0.8, P= 0.434) alleles (Table 2). Similarly, there were
no associations with migraine classic, common and compli-
cated subtypes and IL-4 rs2070874 (G/T) SNP in this popula-
tion (Table 3).
3.2. Association of IL-4 SNP (rs2243250 C/T) and migraine
The C/C, T/C and T/T genotypes of 589 C/T were found in
45%, 44% and 11% in HCs, in comparison with 71.5%, 18%
and 10.5% in migraineurs, respectively. The allele frequency of
IL-4 rs2243250 (C/T) were 67% (C), 33% (T) in HCs and
80.5% (C), 19.5% (T) in migraineurs, respectively. There were
significant associations between TC (OR= 0.256, P= 0.001)
and CC (OR= 0.386, P= 0.00) genotype and also C
(OR= 2.036, P= 0.002) and T (OR= 0.428, P= 0.000)
alleles of IL-4 rs2243250 SNP and migraine (Table 2). TC
genotype could be considered as protective and CC genotype
could be considered as risk factor in migraine headaches.
There were no significant differences between patients and con-
trols for the TT (OR= 0.602, P= 0.287) genotype (Table 2).
There were no associations with migraine subtypes and IL-4
SNP (rs2243250 C/T) in this population (Table 3).
3.3. Association of IL-4 SNP (rs2227284 T/G) and migraine
The G/G, T/G and T/T genotypes of +2979 T/G were found
in 27%, 38% and 35% in HCs, in comparison with 46.5%,n of IL-4 gene polymorphisms.
Digestion pieces
(restriction enzyme)
Amplicon size
Allele C: 178, 45
(BsmAI)
Allele T: 140, 45, 38 (BsmAI)
223 bp
Allele C: 177, 18
(AvaII)
Allele T:195
(AvaII)
195 bp
AC TTT AGG TC
Allele T: 122, 53, 45 (AluI)
Allele G: 122, 98
(AluI)
220 bp
in-4 (IL-4), gene polymorphisms (C-589T, T+2979G, and C-33T) and migraine
t (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.05.001
Table 2 Genotype and allelic frequencies of IL-4, SNPs in patients and control subjects.
SNP (rs number) Genotypes and Alleles Patient n (%) Control n (%) aOR (95% CI) P-value
C-33T (rs2070874) CC 150(79%) 148(74%) 1.00 –
TC 28(15%) 38(19%) 0.727 (0.340–1.557) 0.412
TT 12(6%) 14(7%) 0.846 (0.271–2.636) 0.773
TC+ TT 40(21%) 52(26%) 0.759(0.390–1.477) 0.417
C 164(86%) 167(83.5%) 1.246 (0.712–2.176) 0.438
T 26(14%) 33(16.5%) 0.8 (0.4–1.4) 0.434
C-589T (rs2243250) CC 136(71.5%) 90(45%) 1.00 –
TC 34(18%) 88(44%) 0.256 (0.13–0.502) 0.001***
TT 20(10.5%) 22(11%) 0.602 (0.236–1.533) 0.287
TC+ TT 54(28.5%) 110(55%) 0.325(0.179–0.589) 0.000***
C 153(80.5%) 134(67%) 2.036 (1.279–3.241) 0.002**
T 37(19.5%) 66(33%) 0.428 (0.263–0.696) 0.000***
T + 2979G (rs2227284) GG 88(46%) 54(27%) 1.00 -
TG 58(30.5%) 76(38%) 0.448 (0.237–0.925) 0.029*
TT 44(23.5%) 70(35%) 0.386 (0.188–0.790) 0.009**
GG+ TG 102(54%) 146(73%) 0.429(0.236–0.780) 0.005**
G 117(62%) 92(46%) 1.881 (1.25–2.816) 0.002**
T 73(38%) 108(54%) 0.581 (0.386–0.873) 0.008**
* p< 0.05.
** p< 0.01.
*** p< 0.001: significant p-value.
a Adjusted for sex and age.
4 N. Ramroodi et al.30.5% and 23.5% in migraineurs, respectively. The allele fre-
quency of IL-4 rs2243250 (T/G) were 46% (G), 54% (T) in
HCs and 61% (C), 39% (T) in migraineurs, respectively. There
were significant associations between TG (OR= 0.448,
P= 0.029) and TT (OR= 0.386, P= 0.009) genotypes and
also G (OR = 1.881, P= 0.002) and T (OR= 0.581,
P= 0.008) alleles of IL-4 rs2227284 SNP and migraine
(Table 2). T allele could be considered as protective and C
allele could be considered as risk factor in migraine headaches.
There were no associations with migraine subtypes and IL-4
rs2227284 SNP in this population (Table 3).4. Discussion
Migraine is a severe neurological disorder that causes a strong
throbbing or pulsating pain in one area of the head and can be
accompanied by nausea, vomiting and extreme photophobia
[2]. Several studies used a candidate gene approach to elucidate
genetic contribution to neuropathic pain phenotypes; however,
the data are limited and inconsistent [27]. The genetic back-
ground of migraine consists of common or overlapped path-
ways and the responsible genes may provide insight
regarding the pathophysiological mechanisms that can explain
their comorbidity with migraine [28,29]. Cytokines, small pro-
tein molecules secreted in response to immune stimuli, are
involved in signaling that activates CNS glial cells and this
activation is part of a poorly understood interaction between
immune challenge and host that can lead to the development
or facilitation of pathologic pain [30]. Data from the large
cohort of Caucasian women (n= 25,713) in 77 different SNPs
suggested that there is an association between variants in some
inflammatory mediators including TNF-a rs673 (OR= 0.52,
95% CI = 0.30–0.89, p= 0.017), CCR2 rs1799864Please cite this article in press as: Ramroodi N et al., Association between interleuk
susceptibility in Iranian population: A case–control study, Egypt J Med Hum Gene(OR = 1.12, 95% CI = 1.03–1.21, p= 0.007), TGFB1
rs1800469 (OR= 0.93, 95% CI = 0.89–0.89, p= 0.009),
NOS3 rs3918226 (OR= 1.13, 95% CI = 1.01–1.27,
p= 0.04), and IL-9 rs2069885 (OR= 1.12, 95% CI = 1.02–
1.24, p= 0.02) with migraine [31]. In this study, for the first
time we focused on anti-inflammatory cytokine, IL-4 in
patients with migraine headaches to examine the hypothesis
that say migraine headaches could be caused by change in
immune system [32]. It has been characterized that IL-4 is
required for the generation of the Th2-derived cytokines and
several reports indicate a reduced level of IL-4 during migraine
attack [33–36]. Perini et al. have found no significant differ-
ences between IL-4 plasma levels in migraine patients with
and without aura (p= 0.07); as well as patients outside and
during the attacks (p= 0.06) and also between HCs and
patients (p= 0.06) [16]. Conversely, Sarchielli et al. reported
that levels of IL-4 were reduced at the time of migraine attack
(p< 0.004) and its levels at the end of the attack returned to
those detected at attack onset [35]. Moreover, Munno et al.
suggested that IL-4 plasma levels were decreased during
attacks and undetectable in 62.5% of patients with migraine
headaches without aura [37]. In other study, although no sig-
nificant fluctuations of the IL-4 plasma levels during the
headache-free period in children with migraine and tension-
type headaches have been found, immune dysfunction (abnor-
mal changes in pro- and anti-inflammatory cytokines) in
migraineurs could not be totally excluded [38]. Such controver-
sies may be due to different population studies, long medical
history of migraineurs and frequent intake of prophylactic
drugs or analgesic treatments. In relation to adult glioma,
there were close association between IL4 (rs2243248,
T-1098G), IL6 (rs1800795, G-174C) and overall risk of glioma
[39]. Another study demonstrated no association between IL-4
rs2227284 SNP and rheumatoid arthritis (RA) that is thein-4 (IL-4), gene polymorphisms (C-589T, T+2979G, and C-33T) and migraine
t (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.05.001
Table 3 Genotype and allelic frequencies of IL-4, SNPs in deferent subclasses of migraine.
SNP (rs number) Genotypesand Alleles Common n (%) Classic n (%) Complicated n (%) aOR (95% CI) P-value
C-33T
(rs2070874)
CC 74(77%) 67(85.5%) 8(50%) 1.00 -
TC 12(13%) 11(14.5%) 4(25%) 1.397(0.567–3.44) 0.467
TT 10(10%) 0 4(25%) 1.035(0.271–3.954) 0.959
TC+ TT 22(23%) 11(14.5%) 8(50%) 1.279(0.584–2.801) 0.538
C 80(83%) 73(93%) 10(62.5%) 0.706(0.307–1.623) 0.411
T 16(17%) 5(7%) 6(37.5%) 1.41(0.616–3.251) 0.411
C-589T (rs2243250) CC 68(71%) 60(77%) 8(50%) 1.00 -
TC 13(14%) 15(19%) 4(25%) 1.298(0.559–3.014) 0.544
TT 15(15%) 3(4%) 4(25%) 0.849(0.285–2.528) 0.768
TC+ TT 28(29%) 18(23%) 8(50%) 1.114(0.546–2.271) 0.767
C 84(87%) 67(86%) 10(62.5%) 0.58(0.309–1.093) 0.090
T 12(13%) 11(14%) 6(37.5%) 1.82(0.95–3.459) 0.064
T + 2979G (rs2227284) GG 44(46%) 37(48%) 6(37%) 1.00 -
TG 25(26%) 28(35%) 4(26%) 1.181(0.558–2.498) 0.664
TT 27(28%) 13(17%) 6(37%) 0.942(0.411–2.160) 0.888
TG+ TT 52(54%) 41(52%) 10(63%) 1.073(0.561–2.050) 0.832
G 57(59%) 51(66%) 8(50%) 0.526(0.274–1.006) 0.050
T 39(41%) 27(34%) 8(50%) 1.901(0.993–3.638) 0.050
*p< 0.05, **p< 0.01, ***p< 0.001: significant p-value.
a Adjusted for sex and age.
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that IL-4 gene polymorphisms may influence the function of
mononuclear cells to produce not only IL-4 but also other
cytokines [41]. In the Pakistani cohort study, it has been
reported that the most frequent genotypes of IL-4 in the
asthma and allergic rhinitis groups were TT for SNP
rs2243250, and GG for SNP rs2227284 [42]. As well as, IL-4
rs2070874 was not found to be associated with either asthma
or allergic rhinitis in the Pakistani cohort [42]. Recently Shang
et al. have demonstrated that IL-4 rs2243250 SNP may be
associated with high levels of serum IL-4, which may increase
the risk of atopic dermatitis in children [43]. Lu et al. findings
suggest that SNP in IL-4 rs2070874 (OR: 3.438, 95% CI:
1.032–11.458, P= 0.044) may be a risk factor for hepatocellu-
lar carcinoma in Chinese males [44]. It is notable that, there are
not available any data from previous epidemiological studies
exploring theses IL-4 SNPs in migraineurs population all over
the word. Therefore, our results for the first time provided evi-
dence that enhance our understanding of how migraine may
relate to, an anti-inflammatory cytokine, IL-4 gene variation.
Mentioned reports are relatively conflicting with our recent
leading study (but in different population and disease) which
revealed that the IL-4 rs2243250 SNP in the genotype TC
and also rs2227284 SNP in the genotypes TG and TT playa
protective role. These polymorphisms could resulting to
changing in Th2 release IL-4, or affecting IL-4 affinity to their
cell targets and consequently unbalance between Th1/Th2
cytokines may possibly influence the spreading of pain produc-
ing processes in migraine. IL-4 appears to be a prospective tar-
get for future development of migraine-specific preventive
therapies. The data presented here must be viewed with cau-
tion due to the relatively small number of patients enrolled
and therefore these results should be taken as preliminary.
Similar studies enrolling greater sample sizes and composed
of other ethnic groups from different countries may contribute
to confirming our findings.Please cite this article in press as: Ramroodi N et al., Association between interleuk
susceptibility in Iranian population: A case–control study, Egypt J Med Hum Gene5. Conclusion
In conclusion, our results implicate that the IL-4 rs2243250
(TC) and rs2227284 (TG and TT) SNPs have a protective role
in susceptibility to migraine disease in Iranian patients. No sig-
nificant associations between IL-4 SNP rs2070874 (TC, TT
and CC genotypes) and migraine were found. There was no
statistically significant relationship between these SNPs and
different subclasses (common, classic and complicated) of
migraine.
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